Realistic costs ought to be awarded considering ever-increasing litigation expenses
Facts and Background The Plaintiffs, AstraZeneca, filed a suit (CS (Comm.) 101/2022) at the Delhi High Court seeking a permanent injunction to restrain the Defendant, Westcoast Pharmaceutical Works Limited from infringing their patent IN 297581. The Patent was for the novel compound Osimertinib, used for treating specific types of non-small cell lung cancer. In January…